Bioeconomy Capital
North America, Washington, United States, Seattle
Description
Bioeconomy Capital invests in early-stage companies with the goal of accelerating the biotechnology revolution.
Investor Profile
Bioeconomy Capital has made 16 investments, with 0 in the past 12 months and 31% as lead.
Stage Focus
- Series A (44%)
- Series B (25%)
- Seed (19%)
- Series C (6%)
- Series Unknown (6%)
Country Focus
- United States (81%)
- United Kingdom (19%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Life Science
- Pharmaceutical
- Software
- Bioinformatics
- Genetics
- Analytics
- Industrial Automation
- Information Services
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
